...
首页> 外文期刊>Journal of immunology research. >Clinical Correlations of Novel Autoantibodies in Patients with Dry Eye
【24h】

Clinical Correlations of Novel Autoantibodies in Patients with Dry Eye

机译:新型自身抗体对干眼症患者的临床相关性

获取原文

摘要

Background. Diagnostic criteria for Sj?gren’s syndrome (SS) are continually being updated in pursuit of more precise and earlier diagnosis to prevent its complications. Owing to the high rate of false negative traditional serological markers, the need for better serological testing remains. Objective. To investigate the clinical significance of three recently discovered novel autoantibodies, anti-salivary gland protein 1 (SP1), anti-carbonic anhydrase 6 (CA6), and anti-parotid secretory protein (PSP), in a cohort of dry eye patients with suspected underlying inflammatory/autoimmune disease. Methods. Medical records of 136 patients with a primary diagnosis of dry eye who underwent laboratory testing between April 2014 and July 2017 were reviewed retrospectively. Data regarding demographic information, ocular and systemic symptoms, previous medical diagnoses, serological test results, and minor salivary gland biopsy results were collected. Dry eye evaluations included tear osmolarity, Schirmer test without anesthesia, conjunctival lissamine green staining, and corneal fluorescein staining in the order listed here. Results. Of the 136 patients, 9 (9/136, 6.6%) presented with a history of SS, and 9 additional patients (9/127, 7%) received a new diagnosis of SS as a result of evaluations. Fifty-six patients (56/136, 41%) tested positive for at least one of the novel autoantibodies. Fifty-four percent (6/11) of patients with primary SS who underwent the novel serological testing had a positive anti-PSP. Of those, 2 (2/11, 18%) had negative traditional serology and had to undergo minor salivary gland biopsy for definitive diagnosis. Anti-CA6 was associated with increased corneal and conjunctival staining after adjusting for age, sex, and other serologic markers (HR=1.5, 95% CI=1.20-1.97, and p=0.009 and HR=1.4, 95% CI=1.04-1.76, and p=0.02, respectively). Conclusions. This cross-sectional study demonstrated that anti-CA6 is seen in patients with severe aqueous-deficient dry eye. Whether these patients have an early stage of SS or a different type of autoimmune condition may be determined through longitudinal studies.
机译:背景。 SJ的诊断标准?GREN的综合征(SS)不断更新,以追求更精确和早期的诊断,以防止其并发症。由于假阴性传统血清学标记的高率,仍然需要更好的血清学检测。客观的。为了研究三个最近发现的新型自身抗体,抗唾液腺蛋白1(SP1),抗碳酸酐酶6(CA6)和抗腮腺分泌蛋白(PSP)的临床意义,可疑患者潜在的炎症/自身免疫疾病。方法。回顾性地审查了136例患有136例患者的136名患者的初步诊断,审查了2014年4月至2017年7月的实验室检测。收集了关于人口统计学信息,眼科和全身症状,先前的医学诊断,血清学检测结果和轻微唾液腺活检结果的数据。干眼评估包括泪滴渗透压,没有麻醉,结膜Lissamine绿色染色,以及在这里列出的订单中的角膜荧光蛋白染色。结果。在136名患者中,9名(9/136,6.6%)呈现出SS历史,9名患者(9/127,7%)因评估而获得了对SS的新诊断。五十六名患者(56/136,41%)测试了至少一种新型自身抗体的阳性。经历新型血清学检测的主要SS患者54%(6/11)患有正抗PSP。其中2(2/11,18%)具有负传统血清学,不得不经受轻微的唾液腺活组织检查,以便确定诊断。抗CA6与调整年龄,性别和其他血清学标记物(HR = 1.5,95%CI = 1.20-1.97和P = 0.009和HR = 1.4,95%CI = 1.04- 1.76,分别为P = 0.02)。结论。这种横截面研究表明,在严重的含水缺乏干眼症患者中看到抗CA6。这些患者是否具有SS的早期阶段或不同类型的自身免疫条件可以通过纵向研究来确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号